Pulsatile inhibition of PI3K converts immune suppression by Tregs and M2-TAM to anti-tumor immune response in animal models insensitive or resistant to the monotherapies of PI3K and checkpoint inhibitors

被引：2
作者：
Glaeske, Sarah [1 ]
Huebner, Franziska [1 ]
Anurin, Anna [1 ]
Janzer, Andreas [1 ]
Zitzmann-Kolbe, Sabine [1 ]
Paul, Juliane [1 ]
Glaeske, Katja [1 ]
Berndt, Sandra [1 ]
Mumberg, Dominik [1 ]
Gorjanacz, Matyas [1 ]
Ziegelbauer, Karl [1 ]
Kreft, Bertolt [1 ]
Liu, Ningshu [1 ]
机构：
[1] Bayer AG, Berlin, Germany
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-LB-123
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB-123
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Inhibition of Dickkopf-1 enhances the anti-tumor efficacy of sorafenib via inhibition of the PI3K/Akt and Wnt/β-catenin pathways in hepatocellular carcinoma
    Sang Hyun Seo
    Kyung Joo Cho
    Hye Jung Park
    Hye Won Lee
    Beom Kyung Kim
    Jun Yong Park
    Do Young Kim
    Sang Hoon Ahn
    Jae Hee Cheon
    Jong In Yook
    Man-Deuk Kim
    Dong Jin Joo
    Seung Up Kim
    Cell Communication and Signaling, 21
  • [42] Novel induction of CD40 expression by tumor cells with RAS/RAF/PI3K pathway inhibition augments response to checkpoint blockade
    Yan, Chi
    Saleh, Nabil
    Yang, Jinming
    Nebhan, Caroline A.
    Vilgelm, Anna E.
    Reddy, E. Premkumar
    Roland, Joseph T.
    Johnson, Douglas B.
    Chen, Sheau-Chiann
    Shattuck-Brandt, Rebecca L.
    Ayers, Gregory D.
    Richmond, Ann
    MOLECULAR CANCER, 2021, 20 (01)
  • [43] αvβ5/β6 integrin suppression leads to a stimulation of α2β1 dependent cell migration resistant to PI3K/Akt inhibition
    Defilles, Celine
    Lissitzky, Jean-Claude
    Montero, Marie-Pierre
    Andre, Frederic
    Prevot, Charles
    Delamarre, Estelle
    Marrakchi, Naziha
    Luis, Jose
    Rigot, Veronique
    EXPERIMENTAL CELL RESEARCH, 2009, 315 (11) : 1840 - 1849
  • [44] Novel induction of CD40 expression by tumor cells with RAS/RAF/PI3K pathway inhibition augments response to checkpoint blockade
    Chi Yan
    Nabil Saleh
    Jinming Yang
    Caroline A. Nebhan
    Anna E. Vilgelm
    E. Premkumar Reddy
    Joseph T. Roland
    Douglas B. Johnson
    Sheau-Chiann Chen
    Rebecca L. Shattuck-Brandt
    Gregory D. Ayers
    Ann Richmond
    Molecular Cancer, 20
  • [45] Inhibition of Dickkopf-1 enhances the anti-tumor efficacy of sorafenib via inhibition of the PI3K/Akt and Wnt/β-catenin pathways in hepatocellular carcinoma
    Seo, Sang Hyun
    Cho, Kyung Joo
    Park, Hye Jung
    Lee, Hye Won
    Kim, Beom Kyung
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Cheon, Jae Hee
    Yook, Jong In
    Kim, Man-Deuk
    Joo, Dong Jin
    Kim, Seung Up
    CELL COMMUNICATION AND SIGNALING, 2023, 21 (01)
  • [46] The anti-tumor efficacy of CDK4/6 inhibition is enhanced by the combination with PI3K/AKT/mTOR inhibitors through impairment of glucose metabolism in TNBC cells
    Cretella, Daniele
    Ravelli, Andrea
    Fumarola, Claudia
    La Monica, Silvia
    Digiacomo, Graziana
    Cavazzoni, Andrea
    Alfieri, Roberta
    Biondi, Alessandra
    Generali, Daniele
    Bonelli, Mara
    Petronini, Pier Giorgio
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2018, 37
  • [47] The anti-tumor efficacy of CDK4/6 inhibition is enhanced by the combination with PI3K/AKT/mTOR inhibitors through impairment of glucose metabolism in TNBC cells
    Daniele Cretella
    Andrea Ravelli
    Claudia Fumarola
    Silvia La Monica
    Graziana Digiacomo
    Andrea Cavazzoni
    Roberta Alfieri
    Alessandra Biondi
    Daniele Generali
    Mara Bonelli
    Pier Giorgio Petronini
    Journal of Experimental & Clinical Cancer Research, 37
  • [48] Anti-allergic potential of Typhonium blumei : Inhibition of degranulation via suppression of PI3K/PLCγ2 phosphorylation and calcium influx
    Korinek, Michal
    Chen, Kuan-Ming
    Jiang, Yu-Han
    El-Shazly, Mohamed
    Stocker, Joel
    Chou, Chon-Kit
    Hwang, Tsong-Long
    Wu, Yang-Chang
    Chen, Bing-Hung
    Chang, Fang-Rong
    PHYTOMEDICINE, 2016, 23 (14) : 1706 - 1715
  • [49] PI3K and ERK1/2 kinase inhibition potentiate protease inhibitor to attenuate allergen induced Th2 immune response in mouse
    Saw, Sanjay
    Arora, Naveen
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2016, 776 : 176 - 184
  • [50] PI3Kα/δ inhibition promotes anti-tumor immunity through direct enhancement of effector CD8+ T-cell activity
    Carnevalli, Larissa S.
    Sinclair, Charles
    Taylor, Molly A.
    Gutierrez, Pablo Morentin
    Langdon, Sophie
    Coenen-Stass, Anna M. L.
    Mooney, Lorraine
    Hughes, Adina
    Jarvis, Laura
    Staniszewska, Anna
    Crafter, Claire
    Sidders, Ben
    Hardaker, Elizabeth
    Hudson, Kevin
    Barry, Simon T.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 6
12345